← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2019-04-19

Drug application

FDA Application #

ANDA207448

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

MESALAMINE

Active ingredients

MESALAMINE

Dosage form

SUPPOSITORY

Route

RECTAL

Marketing status

Prescription

Sponsor

RISING

Manufacturer

Rising Pharma Holdings, Inc.

First approval

2019-04-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown